[Modification of the phagocytosis capacity of lung macrophages by intravenous treatment with polyvinylpyridine-N-oxide (Bayer 3504)].
D000818:Animals; D003497:Cyclic N-Oxides / Q000008:administration & dosage / Q000494:pharmacology*; D007275:Injections, Intravenous; D008264:Macrophages / Q000187:drug effects*; D008297:Male; D010587:Phagocytosis / Q000187:drug effects*; D011650:Pulmonary Alveoli / Q000166:cytology*; D051381:Rats
D003497:Cyclic N-Oxides
Die Beeinflussung der Phagocytoseleistung von Lungenmakrophagen durch intravenöse Vorbehandlung mit Polyvinylpyrindin-N-oxyd (Bayer 3504)